# A Feasibility Study of Real-Time FMRI with Neurofeedback of Motor Performance in Cerebellar Ataxia

**Authors:** Joshua G. Berenbaum, Cherie L. Marvel, Jonathan M. Lisinski, Jeffrey S. Soldate, Owen P. Morgan, Ashley N. Kucharski, Luca P. Lutzel, Jonathan A. Ecker, Laura C. Rice, Amy Mistri, Prianca A. Nadkarni, Liana S. Rosenthal, Stephen M. LaConte

PMC · DOI: 10.3390/brainsci16020120 · Brain Sciences · 2026-01-23

## TL;DR

This study explores using real-time fMRI neurofeedback with motor imagery to improve motor function in people with cerebellar ataxia.

## Contribution

The study demonstrates the feasibility of combining motor imagery and real-time fMRI neurofeedback for cerebellar ataxia.

## Key findings

- Tapping accuracy improved in 9 out of 16 participants after neurofeedback training.
- Motor improvements correlated with brain activity in the frontal lobe, insula, and cerebellum during successful motor imagery.
- Tapping accuracy was higher at 1 Hz than at 4 Hz, and error rates reflected movement impairments.

## Abstract

Background/Objectives: Neurodegenerative cerebellar ataxia (CA) is a movement disorder caused by progressive cell death in the cerebellum. Motor imagery represents a potential therapeutic tool to improve motor function by “exercising” brain regions associated with movement, without the need for overt activity. This study assessed the feasibility of combining motor imagery with real-time functional magnetic resonance imaging neurofeedback (rt-fMRI-NF) to improve motor function in CA. Methods: During finger tapping conditions, 16 participants with CA pushed a button at the same frequency in time with cross flashing at 1 Hz or 4 Hz, and this information was used to train the model. During motor imagery, participants imagined finger tapping while undergoing rt-fMRI-NF with visual feedback, steering them toward activating their motor circuit. Afterwards, they completed finger tapping again. FMRI analysis compared successful motor imagery trials versus all other imagery events. Brain activity on successful trials was covaried with pre–post rt-fMRI-NF tapping improvement scores. Results: Tapping was more accurate at 1 Hz than 4 Hz, and larger tapping error rates correlated with greater movement impairments. While not significant at the group level, 9 of the 16 participants improved tapping accuracy following rt-fMRI-NF. The size of motor improvements correlated with successful motor imagery activity at 1 Hz in the frontal lobe, insula, parietal lobe, basal ganglia, and cerebellum. Motor improvements were not associated with neurological impairment severity, mood, cognition, or imagery vividness. Conclusions: Feasibility was demonstrated for motor imagery therapy with neurofeedback to potentially improve fine motor precision in people with CA. Brain regions relevant to this process may be considered for targets of non-invasive therapeutic interventions.

## Linked entities

- **Diseases:** cerebellar ataxia (MONDO:0000437)

## Full-text entities

- **Diseases:** substance use disorder (MESH:D019966), loss of consciousness (MESH:D014474), SCA (MESH:D020754), attention deficit hyperactivity disorder (MESH:D001289), psychotic disorder (MESH:D011618), autism (MESH:D001321), Anxiety (MESH:D001007), dizziness (MESH:D004244), injury to (MESH:D014947), Neurodegenerative (MESH:D019636), loss of eye movement control (MESH:D015835), CA (MESH:D002524), epilepsy (MESH:D004827), problems with speech and swallowing (MESH:D003680), Ataxia (MESH:D001259), head injury (MESH:D006259), impaired vision (MESH:D014786), PD (MESH:D010300), damage to the brain (MESH:D001925), neurologic disorder (MESH:D009461), CCAS (MESH:D002526), neurological impairment (MESH:D009422), impaired cognitive abilities (MESH:D003072), cerebellar degeneration (MESH:D013132), movement disorder (MESH:D009069), motor impairment (MESH:D000068079), neural degeneration (MESH:D009410), CAUE (MESH:D000092702), mood (MESH:D019964), balance and gait difficulties (MESH:D020234), Depression (MESH:D003866), neurological disease (MESH:D020271), NF (MESH:D016518), nystagmus (MESH:D009759), learning disability (MESH:D007859), stroke (MESH:D020521)
- **Chemicals:** baclofen (MESH:D001418), IP (MESH:C041508), oxygen (MESH:D010100), gabapentin (MESH:D000077206), TCP (MESH:C049563)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937812/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12937812/full.md

## References

82 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937812/full.md

---
Source: https://tomesphere.com/paper/PMC12937812